Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Danang Pharmaceutical Medical Equipment JSC (DDN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7,800 0    0.00%
07/05 - Closed. Currency in VND ( Disclaimer )
  • Volume: 110
  • Bid/Ask: 12,100 / 13,500
  • Day's Range: 7,800 - 7,800
Type:  Equity
Market:  Vietnam
ISIN:  VN000000DDN5 
Danang Pharmaceutical Medical Equip 7,800 0 0.00%

DDN Financial Summary

 
A brief financial summary of Danang Pharmaceutical Medical Equipment JSC as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

For the three months ended 31 March 2022, Danang Pharmaceutical Medical Equip JSC revenues decreased 11% to VND314.96B. Net income decreased 27% to VND3.58B. Revenues reflect Sales Returns and Allowances increase of 28% to VND908.1M. Net income also reflects Selling Expense increase of 43% to VND10.93B (expense), Financial Income decrease of 32% to VND2.17B (income).

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DDN Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 314957.1 309737.77 360704.41 520351.24
Gross Profit 17135.08 21113.44 15631.34 20056.8
Operating Income 4255.36 616.84 4599.18 5991.05
Net Income 3580.61 1526.71 3508.46 4948.17

DDN Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 529493.07 532914.84 645339.93 786916.74
Total Liabilities 333313.28 340315.66 454267.46 599352.72
Total Equity 196179.79 192599.18 191072.47 187564.01

DDN Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  4.78%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 3 Months 12 Months 9 Months 6 Months
Cash From Operating Activities 15821.43 45437.22 -4306.43 21270.5
Cash From Investing Activities 15486.67 -27117.73 -617.29 -581.01
Cash From Financing Activities -4111.45 -19903.78 -6489.97 -21616.94
Net Change in Cash 27196.65 -1590.91 -11413.69 -929.33
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DDN Comments

Write your thoughts about Danang Pharmaceutical Medical Equipment JSC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email